» Articles » PMID: 3323928

Alzheimer's Disease As a Presumptive Threshold Phenomenon

Overview
Journal Neurobiol Aging
Publisher Elsevier
Date 1987 Nov 1
PMID 3323928
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

With the example of the basal forebrain cholinergic system as a site of primary importance in AD, the existence of a critical neuron loss as a threshold between normal aging and AD is suggested. If the extent of degeneration exceeds this threshold the system decompensates and the clinical picture becomes apparent. The fully developed stage of AD might, therefore, represent a condition beyond the capacity of compensation where plastic adaptive changes are still present but functionally insufficient.

Citing Articles

Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.

Collins H, Greenfield S Int J Mol Sci. 2024; 25(11).

PMID: 38892408 PMC: 11172947. DOI: 10.3390/ijms25116222.


When Does Alzheimer's Disease Really Start? The Role of Biomarkers.

Lloret A, Esteve D, Lloret M, Cervera-Ferri A, Lopez B, Nepomuceno M Int J Mol Sci. 2019; 20(22).

PMID: 31698826 PMC: 6888399. DOI: 10.3390/ijms20225536.


Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals.

Lazarczyk M, Hof P, Bouras C, Giannakopoulos P BMC Med. 2012; 10:127.

PMID: 23098093 PMC: 3523068. DOI: 10.1186/1741-7015-10-127.


Decreased cerebral α4β2* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography.

Kendziorra K, Wolf H, Meyer P, Barthel H, Hesse S, Becker G Eur J Nucl Med Mol Imaging. 2010; 38(3):515-25.

PMID: 21069319 DOI: 10.1007/s00259-010-1644-5.


Acetylcholine receptors in dementia and mild cognitive impairment.

Sabri O, Kendziorra K, Wolf H, Gertz H, Brust P Eur J Nucl Med Mol Imaging. 2008; 35 Suppl 1:S30-45.

PMID: 18228017 DOI: 10.1007/s00259-007-0701-1.